Phase I randomized dose-ascending placebo-controlled trials of ferroquine - a candidate anti-malarial drug - in adults with asymptomatic <it>Plasmodium falciparum </it>infection by Ospina Salazar Carmen L, Matsiegui Pierre-Blaise, Missinou Michel A, Dal-Bianco Matthias P, Supan Christian, Mombo-Ngoma Ghyslain, Issifou Saadou, Ter-Minassian Daniel, Ramharter Michael, Kombila Maryvonne, Kremsner Peter G, Lell Bertrand

Get full text